KSCM
ORTX

Kamunting Street Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Kamunting Street Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-305
Closed -$55K – 62
2019
Q1 		$55K Hold
305
– – 0.07% 38
2018
Q4 		$48K Buy
+305
New +$45.5K 0.04% 35

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Kamunting Street Capital Management's ORTX Position: Q2 2019 in Review

Kamunting Street Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2019, closing a stake of 305 shares — an estimated $55K sold.

Kamunting Street Capital Management first reported a position in ORTX in Q4 2018 and held it in 2 quarters. The position peaked at $55K in Q1 2019. 68 funds tracked by Wall St. Rank hold ORTX as of Q2 2019.

  • Kamunting Street Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • Kamunting Street Capital Management sold 305 Orchard Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $55K.
  • Kamunting Street Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 2 quarters.
  • Kamunting Street Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $55K in Q1 2019.
  • 68 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Kamunting Street Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.